首页> 外文期刊>Journal of the Chilean Chemical Society >DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION AND SPECTROSCOPIC CHARACTERIZATION OF VILDAGLIPTIN USING II -ACCEPTORS IN PHARMACEUTICAL PREPARATIONS
【24h】

DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION AND SPECTROSCOPIC CHARACTERIZATION OF VILDAGLIPTIN USING II -ACCEPTORS IN PHARMACEUTICAL PREPARATIONS

机译:分光光度法测定和制备药物制剂中使用II-受体的维格列汀的分光光度法的验证

获取原文
       

摘要

Three simple, quick and sensitive methods are described for the spectrophotometric determination of vildagliptin (VLD) in pharmaceutical preparations. The methods are based on formation of colored charge transfer (CT) complexes between VLD as n-electron donor and chloranilic acid (CA), tetrachloro-1,4-benzoquinone (p-chloranil), 7,7,8,8-tetracyanoquinodimethane (TCNQ) as π-acceptors. The colored products were quantitated spectrophotometrically at 520, 535 and 842 nm for CA, p-chloranil and TCNQ methods, respectively. Optimization of different experimental conditions were investigated. Beer's law was obeyed in the concentration range of 20-250 μg mL-1, 25-400 μg mL-1 and 20-500 μg mL-1 for CA, p-chloranil and TCNQ methods, respectively. The formation of the CT-complexes and the sites of interactions were confirmed by elemental analysis using IR, 1H NMR spectroscopy. Validity of the methods in terms of specificity, linearity, accuracy, precision, robustness, limit of detection and limit of quantitation were evaluated. Good recoveries were obtained for all of the methods indicating that no interference was observed from concomitants usually present in dosage forms. The methods were applied successfully to the determination of VLD in pharmaceutical preparations.
机译:介绍了三种简单,快速和灵敏的方法用于分光光度法测定药物制剂中的维格列汀(VLD)。该方法基于在作为正电子供体的VLD与氯苯甲酸(CA),四氯-1,4-苯醌(对氯苯醌),7,7,8,8-四氰基喹二甲烷之间形成有色电荷转移(CT)络合物(TCNQ)作为π受体。用CA,对氯苯胺和TCNQ方法分别在520、535和842 nm处用分光光度法对有色产物进行定量。研究了不同实验条件的优化。对于CA,对氯苯胺和TCNQ方法,分别遵守20-250μgmL-1、25-400μgmL-1和20-500μgmL-1的比尔定律。 CT复合物的形成和相互作用的部位通过使用IR,1 H NMR光谱的元素分析来确认。评估了方法在特异性,线性,准确性,精密度,鲁棒性,检测限和定量限方面的有效性。所有方法均获得了良好的回收率,表明没有观察到通常以剂型存在的伴随药物的干扰。该方法已成功应用于药物制剂中VLD的测定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号